4
Changes in Ownership
KYNTRA BIO, INC. Filed Acc 0001209191-23-034288
EVP, Chief Medical Officer sold 1,090 shares at $18.83 ($20,525)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Eisner Mark EVP, Chief Medical Officer | 2023-06-02 | Sale | −1,090 | $18.83 | $20,525 | 164,904 | D |
| Open-market sales · 1,090 sh · avg $18.83 · $20,525 | |||||||
Loading xslF345X04/doc4.xml…